Since 2011, Orwig’s team has frozen samples from about 1,000 prepubertal boys, according to the AP. Although the testicular tissues do not yet produce sperm due to their immaturity, they produce stem ...

Glucagon-like peptide-1 receptor agonist drugs (GLP-1s) such as Wegovy and Zepbound, have become game-changers in the world of weight-loss drugs. By reducing appetite and slowing down the rate at ...

All rectal cancer patients with a specific genetic mutation had a complete response to the checkpoint inhibitor, and some were still in remission four years later.

Drugs like Wegovy and Zepbound were associated with a 17% lower risk of cancer overall for people with obesity, with greater reductions for specific malignancies.

“Personalized, risk-based screening is critical to improving breast cancer outcomes, and AI tools offer us the best opportunity to fulfill that potential,” said Robert Smith, PhD, senior vice ...

Anxiety about scans, bloodwork and similar tests is a common experience for many people living with and beyond cancer, but they are finding creative ways to ease its grip.

“While all fires pose exposure risks, EV fires elevate the risk to firefighters, owners and the nearby community because they are powered by massive batteries containing high concentrations of heavy ...

From screening through survivorship, cancer patient navigation removes barriers and boosts care. To learn more, read our related feature story “How Patient Navigators Can Help You Get Through a Cancer ...

A next-generation armored CAR-T therapy called C-CAR031 led to regression of liver tumors in more than half of patients with advanced hepatocellular carcinoma, rising to 75% for those who received the ...

Annual conference highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices.

"The only reason I caught this cancer when it is still Stage 0 is because the day I got my text message that my yearly mammogram came up, I made the appointment,” said Fishel, who starred in the Boy ...

Breast cancer is the most common cancer among U.S. women after skin cancer and the leading cause of cancer death in Hispanic women. In 2024, a n estimated 310,720 new cases of invasive breast cancer ...